| Literature DB >> 1840763 |
M Lader1.
Abstract
Buspirone is a newer anxiolytic which differs chemically and pharmacologically from the benzodiazepines. The question as to whether buspirone can induce rebound, dependence, or abuse can be examined through a variety of clinical and control studies, as well as animal studies, together with meticulous follow-up of adverse reports. It is concluded that, on present evidence, the short-term use of buspirone is unlikely to be followed by rebound or long-term use through dependence; nor is abuse likely to be a problem.Entities:
Mesh:
Substances:
Year: 1991 PMID: 1840763
Source DB: PubMed Journal: Br J Psychiatry Suppl ISSN: 0960-5371